Last reviewed · How we verify

NCT03690219

Prevalence of Acute Injuries in Amateur and Elite Mountain Bikers

Completed Results posted Last updated 20 October 2025
What this trial tests

trial testing no intervention in Acute Injury in Mountain Biking in 99 participants. Completed in 16 September 2017.

Timeline
11 September 2017
Primary endpoint
16 September 2017
16 September 2017

Quick facts

Lead sponsorUniversity of Applied Sciences and Arts of Southern Switzerland
StatusCompleted
Study typeOBSERVATIONAL
Enrollment99
Start date11 September 2017
Primary completion16 September 2017
Estimated completion16 September 2017
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Applied Sciences and Arts of Southern Switzerland

Who can join

Eligibility, any sex, with Acute Injury in Mountain Biking. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Prevalence of Injuries in Amateur and Elite Mountain Bikers Primary · At study enrollment, based on participants' self-reported history of mountain bike injuries

In a retrospective questionnaire participants were asked about the "Number of injuries obtained during mountain biking".

GroupValue95% CI
Elite Mountain Bikers4.6± 5.5
Amateur Mountain Bikers3.5± 4.3
Training and Racing Volume Secondary · At study enrollment, based on participants' retrospective self-report of the number of races per year and estimated training hours per week

In a retrospective questionnaire the participants were asked "How many races per year" they ride and whats their "Estimated training hours per week in regard to the season". The number of races per year was multiplied by the factor 4 to transform the number of races into training hours. Then, both values were added to get the training volume per year.

GroupValue95% CI
Elite Mountain Bikers743.86± 238.12
Amateur Mountain Bikers443.1± 214.13
Years Practising Mountain Biking Secondary · At study enrollment, based on participants' self-reported history of mountain bike participation

In a retrospective questionnaire participants were asked "Since how many years do you participate in mountain biking?".

GroupValue95% CI
Elite Mountain Bikers15.73± 6.78
Amateur Mountain Bikers15.29± 8.89
Amount of Protective Gear Items Secondary · At study enrollment, based on participants' retrospective self-report of protective gear use

In a retrospective questionnaire participants were asked to tick the protective gear (helment, gloves, eveywear, upper armour, lower armout, other) they are using for mountain biking.

GroupValue95% CI
Elite Mountain Bikers3.20± 0.77
Amateur Mountain Bikers3.24± 0.73
Injury Rate Per 1000hrs Exposure Time Secondary · At study enrollment, based on participants' self-reported history of mountain bike participation

The injury rate per 1000 hours exposure time was calculated as follows: the hours of exposure time per year were multiplied by the number of years practicing mountain biking to get the total hours at risk. Then, the total amount of injuries ever was divided by the total hours at risk, multiplied by 1000 hours to get the injury rate per 1000 hours of exposure time.

GroupValue95% CI
Elite Mountain Bikers0.39
Amateur Mountain Bikers0.52

Sponsor's own description

The investigators intented to assess the prevalence of acute injuries in amateur and elite mountain bikers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

Other University of Applied Sciences and Arts of Southern Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03690219.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing